Palmitoylethanolamide
| Names | |
|---|---|
| Preferred IUPAC name N-(2-Hydroxyethyl)hexadecanamide | |
| Other names 
 | |
| Identifiers | |
| 3D model (JSmol) | |
| Abbreviations | PEA | 
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.008.062 | 
| EC Number | 
 | 
| KEGG | |
| MeSH | palmidrol | 
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C18H37NO2 | |
| Molar mass | 299.499 g·mol−1 | 
| Appearance | White crystals | 
| Density | 910 mg mL−1 | 
| Melting point | 93 to 98 °C (199 to 208 °F; 366 to 371 K) | 
| log P | 5.796 | 
| Hazards | |
| Flash point | 323.9 °C (615.0 °F; 597.0 K) | 
| Related compounds | |
| Related compounds | |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Palmitoylethanolamide (PEA) is an endogenous fatty acid amide, and lipid modulator.
A main target of PEA is proposed to be the peroxisome proliferator-activated receptor alpha (PPAR-α). PEA also has affinity to cannabinoid-like G-coupled receptors GPR55 and GPR119. PEA cannot strictly be considered a classic endocannabinoid because it lacks affinity for the cannabinoid receptors CB1 and CB2.